Rapid Analysis of Outcomes Using the Systemic Anti-Cancer Therapy (SACT) Dataset.
We audited the accuracy of the Systemic Anti-Cancer Therapy dataset as a resource for rapid analysis of outcomes for patients, in this example, receiving Cancer Drug Fund funded monoclonal antibodies to treat metastatic colorectal cancer. We concluded that the Systemic Anti-Cancer Therapy dataset is a potentially valuable resource for rapidly determining survival outcome for patients treated with chemotherapy.
University of Manchester, Manchester, UK. Electronic address: ryan.pathak@manchester.ac.uk.
R
R
Pathak
National Cancer Registration and Analysis Service, Public Health England, London, UK.
M
M
Wallington
St Andrews Medical School, St Andrews, UK.
C
C
Saunders
The Christie NHS Foundation Trust, Manchester, UK.
M
M
Braun
The Christie NHS Foundation Trust, Manchester, UK.
S
S
Mullamitha
The Christie NHS Foundation Trust, Manchester, UK.
G
G
Wilson
The Christie NHS Foundation Trust, Manchester, UK.
J
J
Hasan
Leeds Teaching Hospitals NHS Trust, Leeds, UK.
D
D
Dodwell
National Cancer Registration and Analysis Service, Public Health England, London, UK.
M
M
Bomb
The Christie NHS Foundation Trust, Manchester, UK.
M
M
Saunders
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D000068818:Cetuximab
CDF; Cancer Drug Fund; SACT; Systemic Anti-Cancer Therapy dataset; cetuximab; colorectal